Superparamagnetic Nanoparticles Direct Differentiation of Embryonic Stem Cells Into Skeletal Muscle Cells

2014 ◽  
Vol 4 (7) ◽  
pp. 579-585 ◽  
Author(s):  
Tannaz Norizadeh-Abbariki ◽  
Omid Mashinchian ◽  
Mohammad Ali Shokrgozar ◽  
Nooshin Haghighipour ◽  
Tapas Sen ◽  
...  
Cell Reports ◽  
2013 ◽  
Vol 3 (3) ◽  
pp. 661-670 ◽  
Author(s):  
Sonia Albini ◽  
Paula Coutinho ◽  
Barbora Malecova ◽  
Lorenzo Giordani ◽  
Alex Savchenko ◽  
...  

2017 ◽  
Vol 2017 ◽  
pp. 1-16 ◽  
Author(s):  
Yusaku Kodaka ◽  
Gemachu Rabu ◽  
Atsushi Asakura

Embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) have the potential to differentiate into various types of cells including skeletal muscle cells. The approach of converting ESCs/iPSCs into skeletal muscle cells offers hope for patients afflicted with the skeletal muscle diseases such as the Duchenne muscular dystrophy (DMD). Patient-derived iPSCs are an especially ideal cell source to obtain an unlimited number of myogenic cells that escape immune rejection after engraftment. Currently, there are several approaches to induce differentiation of ESCs and iPSCs to skeletal muscle. A key to the generation of skeletal muscle cells from ESCs/iPSCs is the mimicking of embryonic mesodermal induction followed by myogenic induction. Thus, current approaches of skeletal muscle cell induction of ESCs/iPSCs utilize techniques including overexpression of myogenic transcription factors such as MyoD or Pax3, using small molecules to induce mesodermal cells followed by myogenic progenitor cells, and utilizing epigenetic myogenic memory existing in muscle cell-derived iPSCs. This review summarizes the current methods used in myogenic differentiation and highlights areas of recent improvement.


Blood ◽  
2005 ◽  
Vol 106 (11) ◽  
pp. 1702-1702
Author(s):  
Michael J. Burke ◽  
Patrick Kennedy ◽  
Lei Wang ◽  
Devang Bhatt ◽  
William T. Tse

Abstract The hemangioblast, the progenitor common to hematopoetic and endothelial lineages, expresses the vascular endothelial growth factor (VEGF) receptor flk-1 on its surface. Based on lineage-tracking studies indicating that skeletal muscle cells are derived from flk-1-expressing precursors (Sato et al. Genesis35:153–159, 2003), we tested the hypothesis that the hemangioblast is also a progenitor to the muscle lineage. We studied the development of skeletal muscle progentiors from mouse embryonic stem cells cultured in suspension to form embryoid bodies (EB). These EB were harvested at different time points, disaggregated into single cells and analyzed by flow cytometry. After 10–18 days of culture, the EB contained abundant cells that expressed α7-integrin, a skeletal muscle-specific cell surface antigen. Immunofluorescence microscopic study of sorted and cytospun α7-integrin-positive cells from EB revealed positive staining with MyoD, sarcomeric α-actinin and desmin antibodies, indicating that they were bona fide muscle cells. To test if these muscle cells were derived from hemangioblasts, green fluorescent protein (GFP)-expressing EB were collected at day 4 of development, disaggregated into single cells and replated in methylcellulose medium with the addition of VEGF, stem cell factor and thrombopoietin. After 5 days in methylcellulose culture, clusters of loosely aggregated cells appeared. These cells have features characteristic of hemangioblasts and exhibit large nuclear-to-cytoplasmic ratios. The hemangioblast colonies were individually picked, diaggregated into single cells and plated with a myoblastic cell line (C2C12 cells) in media containing 10% fetal calf serum. Co-culturing of the hemangioblasts with a myoblastic feeder layer was designed to provide the environmental signals necessary for myogenic development. After 48 hours, the co-culture medium was changed to 2% serum to promote muscle differentiation. Three days later, the plates were fixed and analyzed. A small number of GFP-expressing cells assumed an elongated, multinucleated, myofiber-like appearance and stained positiviely for skeletal muscle markers α7-integrin and desmin. We next tested the myogenic potential of hemangioblasts in vivo. The tibialis anterior muscles of C57BL/6 mice were injected with cardiotoxin, a protein kinase inhibitor that depolarizes muscle fibers and induces muscle regeneration. After two days, hemangioblast colonies were picked from methylcellulose culture and injected into the regenerating muscles. Occasional GFP-expressing fibers that stained positive for desmin were seen when analyzed several weeks post-injection. These results indicate that the hemangioblast may be a progenitor not only to hematopoetic and endothelial lineages, but also to skeletal muscle. Future experiments include investigating the significance and mechanism of the hemangioblast’s development into muscle and explore the role of cell-cell fusion in this phenomenon.


2017 ◽  
Vol 70 (16) ◽  
pp. C70
Author(s):  
Chengfei Peng ◽  
Xiaoping Shao ◽  
Xiaoxiang Tian ◽  
Chenghui Yan ◽  
Yaling Han ◽  
...  

2009 ◽  
Vol 36 (1) ◽  
pp. 61-74 ◽  
Author(s):  
Aster H. Juan ◽  
Roshan M. Kumar ◽  
Joseph G. Marx ◽  
Richard A. Young ◽  
Vittorio Sartorelli

2006 ◽  
Vol 18 (2) ◽  
pp. 173
Author(s):  
T. Gibson ◽  
T. Quebedeaux ◽  
S. Rajasekaran ◽  
C. Brenner

Mitochondria are the most abundant organelles in mammalian oocytes and early embryos. Previous data have shown that mitochondrial DNA (mtDNA) deletions are present both in human oocytes and in embryos from in vitro fertilization (IVF) patients and suggest that accumulation of these deletions may contribute to mitochondrial dysfunction and impaired ATP production. In addition, high levels of mitochondrial mutations are present in skeletal muscle fibers from aged rhesus macaques. The specific aims of this study were to determine whether the mitochondrial common deletion is present in non-human primate oocytes and embryos generated by IVF and to determine whether mtDNA mutations are already present in immature oocytes from rhesus ovaries. Using a nested primer polymerase chain reaction (PCR) strategy, we determined the frequency of the rhesus common deletion in immature oocytes compared with stimulated oocytes and embryos. There was a low incidence (21%) of the rhesus common deletion present in immature, unstimulated oocytes derived from necropsied ovaries of 2 to 10-yr-old rhesus macaques. However, there was >3-fold increase (71.4%) in the frequency of deleted mtDNA in stimulated oocytes and IVF embryos from age-matched fertile monkeys. We postulated that, in addition to skeletal muscle, a similar time-dependent accumulation of mtDNA deletions occurs in fertile rhesus macaque oocytes and embryos. We are now investigating the effects of culture and passage number on mtDNA deletions in primate adult and embryonic stem cells. We propose the rhesus monkey to be an excellent model to assess the quality of gametes and embryos, as well as stem cells, and their developmental competence in human and non-human primates. This study was supported by National Institutes of Health grants RR15395 and HD045966.


2019 ◽  
Vol 20 (16) ◽  
pp. 3932 ◽  
Author(s):  
Barbara Świerczek-Lasek ◽  
Jacek Neska ◽  
Agata Kominek ◽  
Łukasz Tolak ◽  
Tomasz Czajkowski ◽  
...  

Pluripotent stem cells convert into skeletal muscle tissue during teratoma formation or chimeric animal development. Thus, they are characterized by naive myogenic potential. Numerous attempts have been made to develop protocols enabling efficient and safe conversion of pluripotent stem cells into functional myogenic cells in vitro. Despite significant progress in the field, generation of myogenic cells from pluripotent stem cells is still challenging—i.e., currently available methods require genetic modifications, animal-derived reagents, or are long lasting—and, therefore, should be further improved. In the current study, we investigated the influence of interleukin 4, a factor regulating inter alia migration and fusion of myogenic cells and necessary for proper skeletal muscle development and maintenance, on pluripotent stem cells. We assessed the impact of interleukin 4 on proliferation, selected gene expression, and ability to fuse in case of both undifferentiated and differentiating mouse embryonic stem cells. Our results revealed that interleukin 4 slightly improves fusion of pluripotent stem cells with myoblasts leading to the formation of hybrid myotubes. Moreover, it increases the level of early myogenic genes such as Mesogenin1, Pax3, and Pax7 in differentiating embryonic stem cells. Thus, interleukin 4 moderately enhances competence of mouse pluripotent stem cells for myogenic conversion.


Sign in / Sign up

Export Citation Format

Share Document